AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Fear of Recurrence and Stopping Immunotherapy

RecruitingNAAges 21 Years - anyAllUniversity of Pittsburgh
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 21 years and older * Fluent in English * Diagnosis of cancer and history of treatment with immunotherapy Exclusion Criteria: * Active suicidal ideation, delusions or hallucinations
๐Ÿ’Š

What it tests

  • cognitive behavioral therapy
๐Ÿ“

Where

1 site
UPMC Hillman Cancer Centers
Pittsburgh, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy